Stool Testing for Colorectal Cancer Screening

Douglas J. Robertson, Thomas Imperiale

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Colorectal cancer (CRC) screening has been shown to reduce CRC incidence and mortality and is widely recommended. However, despite the demonstrated benefits of screening and ongoing efforts to improve screening rates, a large percentage of the population remains unscreened. Noninvasive stool based tests offer great opportunity to enhance screening uptake. The evidence supporting the use of both fecal immunochemical testing (FIT) and stool DNA (sDNA) has been growing rapidly and both tests are now commercially available for use. Other stool biomarkers (eg, RNA and protein based) are also actively under study both for use independently and as adjuncts to the currently available tests. This mini review provides current, state of the art knowledge about noninvasive stool based screening. It includes a more detailed examination of those tests currently in use (ie, FIT and sDNA) but also provides an overview of stool testing options under development (ie, protein and RNA).

Original languageEnglish
Pages (from-to)1286-1293
Number of pages8
JournalGastroenterology
Volume149
Issue number5
DOIs
StatePublished - Oct 1 2015

Fingerprint

Early Detection of Cancer
Colorectal Neoplasms
RNA
DNA
Proteins
Biomarkers
Mortality
Incidence
Population

Keywords

  • Biomarkers
  • Colorectal Cancer Screening
  • Fecal Immunochemical Test
  • Stool DNA

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Stool Testing for Colorectal Cancer Screening. / Robertson, Douglas J.; Imperiale, Thomas.

In: Gastroenterology, Vol. 149, No. 5, 01.10.2015, p. 1286-1293.

Research output: Contribution to journalArticle

Robertson, Douglas J. ; Imperiale, Thomas. / Stool Testing for Colorectal Cancer Screening. In: Gastroenterology. 2015 ; Vol. 149, No. 5. pp. 1286-1293.
@article{47e09560f48142a88f4829f78476397d,
title = "Stool Testing for Colorectal Cancer Screening",
abstract = "Colorectal cancer (CRC) screening has been shown to reduce CRC incidence and mortality and is widely recommended. However, despite the demonstrated benefits of screening and ongoing efforts to improve screening rates, a large percentage of the population remains unscreened. Noninvasive stool based tests offer great opportunity to enhance screening uptake. The evidence supporting the use of both fecal immunochemical testing (FIT) and stool DNA (sDNA) has been growing rapidly and both tests are now commercially available for use. Other stool biomarkers (eg, RNA and protein based) are also actively under study both for use independently and as adjuncts to the currently available tests. This mini review provides current, state of the art knowledge about noninvasive stool based screening. It includes a more detailed examination of those tests currently in use (ie, FIT and sDNA) but also provides an overview of stool testing options under development (ie, protein and RNA).",
keywords = "Biomarkers, Colorectal Cancer Screening, Fecal Immunochemical Test, Stool DNA",
author = "Robertson, {Douglas J.} and Thomas Imperiale",
year = "2015",
month = "10",
day = "1",
doi = "10.1053/j.gastro.2015.05.045",
language = "English",
volume = "149",
pages = "1286--1293",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Stool Testing for Colorectal Cancer Screening

AU - Robertson, Douglas J.

AU - Imperiale, Thomas

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Colorectal cancer (CRC) screening has been shown to reduce CRC incidence and mortality and is widely recommended. However, despite the demonstrated benefits of screening and ongoing efforts to improve screening rates, a large percentage of the population remains unscreened. Noninvasive stool based tests offer great opportunity to enhance screening uptake. The evidence supporting the use of both fecal immunochemical testing (FIT) and stool DNA (sDNA) has been growing rapidly and both tests are now commercially available for use. Other stool biomarkers (eg, RNA and protein based) are also actively under study both for use independently and as adjuncts to the currently available tests. This mini review provides current, state of the art knowledge about noninvasive stool based screening. It includes a more detailed examination of those tests currently in use (ie, FIT and sDNA) but also provides an overview of stool testing options under development (ie, protein and RNA).

AB - Colorectal cancer (CRC) screening has been shown to reduce CRC incidence and mortality and is widely recommended. However, despite the demonstrated benefits of screening and ongoing efforts to improve screening rates, a large percentage of the population remains unscreened. Noninvasive stool based tests offer great opportunity to enhance screening uptake. The evidence supporting the use of both fecal immunochemical testing (FIT) and stool DNA (sDNA) has been growing rapidly and both tests are now commercially available for use. Other stool biomarkers (eg, RNA and protein based) are also actively under study both for use independently and as adjuncts to the currently available tests. This mini review provides current, state of the art knowledge about noninvasive stool based screening. It includes a more detailed examination of those tests currently in use (ie, FIT and sDNA) but also provides an overview of stool testing options under development (ie, protein and RNA).

KW - Biomarkers

KW - Colorectal Cancer Screening

KW - Fecal Immunochemical Test

KW - Stool DNA

UR - http://www.scopus.com/inward/record.url?scp=84943255921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943255921&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2015.05.045

DO - 10.1053/j.gastro.2015.05.045

M3 - Article

VL - 149

SP - 1286

EP - 1293

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 5

ER -